No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CTVA240816C55000
- 1.89
- +0.02+1.07%
15min DelayClose Jul 22 16:00 ET
2.05High1.45Low
2.05Open1.87Pre Close98 Volume2.70K Open Interest55.00Strike Price17.57KTurnover32.53%IV3.87%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry1.89Extrinsic Value100Contract SizeAmericanOptions Type0.5143Delta0.0852Gamma29.61Leverage Ratio-0.0412Theta0.0181Rho15.23Eff Leverage0.0573Vega
Intraday
- 5D
- Daily
News
Has Corteva, Inc. (NYSE:CTVA) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Most readers would already know that Corteva's (NYSE:CTVA) stock increased by 3.6% over the past week. We wonder if and what role the company's financials play in that price change as a company's
BNP Paribas Exane Adjusts Price Target on Corteva to $57 From $58
Corteva (CTVA) has an average outperform rating and price target range of $56 to $70, according to analysts polled by Capital IQ.Price: 55.03, Change: -0.51, Percent Change: -0.92
What to Expect From Corteva's Next Quarterly Earnings Report
Wells Fargo Maintains Corteva(CTVA.US) With Buy Rating, Maintains Target Price $67
Wells Fargo analyst Richard Garchitorena maintains $Corteva(CTVA.US)$ with a buy rating, and maintains the target price at $67.According to TipRanks data, the analyst has a success rate of 18.8% and
New Buy Rating for Corteva (CTVA), the Basic Materials Giant
These 4 Measures Indicate That Corteva (NYSE:CTVA) Is Using Debt Extensively
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
Comments
Morning Movers
Gapping up
$Citigroup(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
Gapping up
$Citigroup(C.US$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock(BLK.US$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life(GL.US$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
27
1
Corteva's rising ROCE and efficient capital use are promising, but growing current liabilities may pose new risks. Despite this, the stock has given a decent 23% return over the past three years, indicating these developments are gaining deserved attention.
1
Corteva's high P/E ratio is sustained by its projected growth surpassing the broader market. Shareholders are at ease with the P/E, confident in the company's future earnings. The share price isn't anticipated to drop significantly soon under these conditions.
The CEO of Lavie Bio, Amit Noam, expressed satisfaction at achieving this milestone with Corteva, stating that the agreement showcases Lavie Bio's technological capabilities and enables the swift introduction of groundbreaking ag-biological solutions.
Corteva's guidance dispels concerns of lower earnings due to falling crop prices. Aptiv's 2024 forecast predicts a 7% sales growth despite stagnant global auto production. TD Cowen analyst Gautam Khanna deems Trane's results as 'good enough', rating the stock as Buy with a $235 price target.
Read more
Peanny : Based on Lies…. The truth is on its way.